| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-05 |